Academic Journal
Monounsaturated fatty acid biosynthesis is critical for streptococcal envelope homeostasis and stress tolerance.
| Τίτλος: | Monounsaturated fatty acid biosynthesis is critical for streptococcal envelope homeostasis and stress tolerance. |
|---|---|
| Συγγραφείς: | Baker JL; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; Department of Biomedical Engineering, OHSU School of Medicine, Portland, Oregon, USA., Tang J; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; KCGIP, Knight Campus for Accelerating Scientific Impact, University of Oregon, Eugene, Oregon, USA., Guo M; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA., Farias-da-Silva FF; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; Department of Public Health, Pediatric Dentistry and Orthodontics, Faculdade de Odontologia de Piracicaba Universidade Estadual de Campinas, Piracicaba, São Paulo, Brazil., Barbisan M; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA., Burnside M; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA., Crofton K; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; Department of Biology, Rollins College, Winter Park, Florida, USA., Williams S; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; Adams School of Dentistry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Rao S; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; Department of Statistics, Santa Clara University, Santa Clara, California, USA., Lee M; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; Department of Biology, Oregon State University, Corvallis, Oregon, USA., Drucker SG; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; Department of Biology, Scripps College, Claremont, California, USA., Kim D; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA., Higashi D; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA., Merritt J; Department of Biomaterial & Biomedical Sciences, OHSU School of Dentistry, Portland, Oregon, USA.; Department of Molecular Microbiology and Immunology, OHSU School of Medicine, Portland, Oregon, USA., Hirose Y; Department of Oral and Molecular Microbiology, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan., Veening J-W; Department of Fundamental Microbiology, Faculty of Biology & Medicine, University of Lausanne, Lausanne, Switzerland., Nizet V; Department of Pediatrics, UC San Diego School of Medicine, La Jolla, California, USA.; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA. |
| Πηγή: | Journal of bacteriology [J Bacteriol] 2026 Sep 17; Vol. 208 (9), pp. e0002626. Date of Electronic Publication: 2026 Aug 07. |
| Τύπος έκδοσης: | Journal Article |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 2985120R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-5530 (Electronic) Linking ISSN: 00219193 NLM ISO Abbreviation: J Bacteriol Subsets: MEDLINE |
| Imprint Name(s): | Original Publication: Washington, DC : American Society for Microbiology |
| Ιατρικοί όροι (MeSH): | Streptococcus mutans*/metabolism , Streptococcus mutans*/genetics , Streptococcus mutans*/physiology , Fatty Acids, Monounsaturated*/metabolism , Streptococcus pneumoniae*/metabolism , Streptococcus pneumoniae*/genetics , Streptococcus pneumoniae*/physiology , Streptococcus pneumoniae*/pathogenicity , Streptococcus pyogenes*/metabolism , Streptococcus pyogenes*/genetics , Streptococcus pyogenes*/physiology , Streptococcus pyogenes*/pathogenicity , Homeostasis* , Stress, Physiological*, Cell Membrane/metabolism ; Humans ; Virulence ; Gene Deletion |
| Περίληψη: | The genus Streptococcus contains some of the most important commensals and pathogens of the human microbiome. To obtain the fatty acids required for cell membranes, Streptococcus either produce fatty acids de novo through the fatty acid biosynthesis (fab) pathway or uptake host fatty acids through the fatty acid kinase (fak) pathway. Although both the fab and fak pathways represent potential therapeutic targets to prevent or treat infection, progress is limited because of an incomplete understanding of taxon-to-taxon variability in streptococcal lipid metabolism. Here, we examined the role of de novo monounsaturated fatty acid (MUFA) synthesis in physiology and virulence-associated traits in Streptococcus mutans, Streptococcus pyogenes, and Streptococcus pneumoniae, three major pathogens that cause disease at distinct body sites. In all three species, deletion of fabM abolished MUFA production and caused severe growth defects, decreased stress tolerance, increased antibiotic susceptibility, and defects in cell viability, morphology, and division. In S. mutans, loss of fabM also markedly reduced competence signaling and production of the mutacin IV bacteriocin. Deletion of fabM increased susceptibility to killing by human neutrophils in S. mutans and S. pneumoniae, but not S. pyogenes. Together, these findings illustrate that MUFA synthesis is broadly important for streptococcal physiology and cell membrane homeostasis, while its contribution to pathogenesis is strongly species- and context-dependent, providing leads to guide the development of novel therapeutic and/or preventative strategies.IMPORTANCEStreptococcus spp. exert profound effects on human health, with several species causing significant morbidity and mortality. Although streptococcal fatty acid biosynthesis and utilization are attractive metabolic targets for development of therapeutics, this opportunity is vexed by an incomplete understanding of taxon-to-taxon variability in lipid metabolism. In this study, the role of de novo monounsaturated fatty acid (MUFA) synthesis in physiology and virulence-associated traits was examined in Streptococcus mutans, Streptococcus pyogenes, and Streptococcus pneumoniae, three major pathogens that cause disease at distinct body sites. MUFA synthesis was important for stress and antibiotic tolerance across all three species, while its impact on virulence was species- and context-dependent. Overall, these discoveries provide leads to guide the development of novel therapeutic and/or preventative strategies. |
| Competing Interests: | The authors declare no conflict of interest. |
| Σχόλια: | Update of: bioRxiv. 2026 Jan 14:2026.01.14.699484. doi: 10.64898/2026.01.14.699484.. (PMID: 41648328) |
| References: | mSphere. 2021 Jun 30;6(3):e0014521. (PMID: 34192504) Virulence. 2024 Dec;15(1):2412745. (PMID: 39370779) Antimicrob Agents Chemother. 2013 Nov;57(11):5729-32. (PMID: 23979734) J Bacteriol. 2015 Dec;197(23):3645-57. (PMID: 26350138) Mol Oral Microbiol. 2015 Dec;30(6):496-517. (PMID: 26042838) Chem Sci. 2024 Jan 31;15(10):3408-3427. (PMID: 38455013) Int J Mol Sci. 2018 Jan 10;19(1):. (PMID: 29320462) Mol Oral Microbiol. 2015 Dec;30(6):474-95. (PMID: 25973955) J Bacteriol. 2003 Feb;185(4):1208-17. (PMID: 12562790) Curr Opin Microbiol. 2011 Oct;14(5):544-9. (PMID: 21862391) Nat Biotechnol. 2021 Feb;39(2):169-173. (PMID: 33169034) J Bacteriol. 2004 Jul;186(13):4152-8. (PMID: 15205416) Mol Microbiol. 2016 Jul;101(1):12-26. (PMID: 26691161) FEMS Microbiol Rev. 2015 Jul;39(4):488-508. (PMID: 25670736) Sci Adv. 2022 Sep 2;8(35):eabq3944. (PMID: 36054360) Nat Commun. 2024 Oct 4;15(1):8593. (PMID: 39366941) J Biol Chem. 2019 Nov 1;294(44):16416-16428. (PMID: 31530637) Microbiol Spectr. 2018 Oct;6(5):. (PMID: 30338752) J Bacteriol. 2007 Nov;189(22):8139-44. (PMID: 17827283) mBio. 2021 Jun 29;12(3):e0092821. (PMID: 34134515) Nat Rev Microbiol. 2023 Jul;21(7):431-447. (PMID: 36894668) Nature. 2009 Mar 5;458(7234):83-6. (PMID: 19262672) Front Oral Health. 2022 Jan 07;2:796140. (PMID: 35048077) Mol Microbiol. 2006 Jan;59(2):551-66. (PMID: 16390449) Nat Protoc. 2024 Sep;19(9):2597-2641. (PMID: 38769143) Science. 2001 Jul 20;293(5529):498-506. (PMID: 11463916) Virulence. 2018;9(1):1576-1587. (PMID: 30251911) Lipids. 2014 Jun;49(6):543-54. (PMID: 24748493) Biochim Biophys Acta. 2010 Sep;1801(9):1098-104. (PMID: 20601114) Nat Commun. 2016 Oct 05;7:12944. (PMID: 27703138) Front Microbiol. 2019 Mar 18;10:351. (PMID: 30936851) Front Cell Infect Microbiol. 2019 Mar 12;9:55. (PMID: 30915281) Environ Microbiol. 2021 May;23(5):2683-2691. (PMID: 33830615) Appl Environ Microbiol. 2012 Feb;78(4):1215-27. (PMID: 22179247) Prog Lipid Res. 2001 Nov;40(6):467-97. (PMID: 11591436) Biochim Biophys Acta. 2007 Mar;1768(3):590-7. (PMID: 17292324) Membranes (Basel). 2023 Apr 10;13(4):. (PMID: 37103850) Microbiol Spectr. 2024 Jan 11;12(1):e0329723. (PMID: 38038454) PLoS One. 2023 Apr 27;18(4):e0284402. (PMID: 37104252) Infect Immun. 2022 Dec 15;90(12):e0047122. (PMID: 36409115) BMC Microbiol. 2016 Nov 9;16(1):271. (PMID: 27829373) Microbiol Spectr. 2019 Jan;7(1):. (PMID: 30657107) J Microbiol. 2021 Dec;59(12):1142-1149. (PMID: 34865199) FEMS Microbiol Lett. 2004 Sep 15;238(2):291-5. (PMID: 15358413) Mol Cell. 2006 Sep 1;23(5):765-72. (PMID: 16949372) Infect Immun. 2007 Mar;75(3):1537-9. (PMID: 17220314) Mol Oral Microbiol. 2012 Apr;27(2):57-69. (PMID: 22394465) Methods Mol Biol. 2019;1997:319-345. (PMID: 31119632) Prog Lipid Res. 2013 Jul;52(3):249-76. (PMID: 23500459) Nat Rev Microbiol. 2025 Apr;23(4):256-271. (PMID: 39506137) Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14434-9. (PMID: 12397186) J Bacteriol. 2007 Sep;189(18):6532-9. (PMID: 17631628) Proc Natl Acad Sci U S A. 2011 Sep 13;108(37):15378-83. (PMID: 21876172) Annu Rev Microbiol. 2022 Sep 8;76:281-304. (PMID: 35650664) J Bacteriol. 1999 Sep;181(18):5790-9. (PMID: 10482522) Nature. 2009 Mar 5;458(7234):39-40. (PMID: 19262660) mBio. 2024 Aug 14;15(8):e0084024. (PMID: 38953375) J Biol Chem. 2002 Nov 22;277(47):44809-16. (PMID: 12237320) Infect Immun. 2000 Jun;68(6):3523-34. (PMID: 10816507) J Bacteriol. 2008 May;190(10):3572-9. (PMID: 18344365) AMB Express. 2024 Oct 1;14(1):110. (PMID: 39354164) mBio. 2025 Feb 05;16(2):e0299324. (PMID: 39688419) FEMS Microbiol Lett. 1999 Mar 15;172(2):131-5. (PMID: 10188240) NPJ Biofilms Microbiomes. 2024 Mar 13;10(1):21. (PMID: 38480745) Gene. 1998 Sep 28;219(1-2):91-9. (PMID: 9757005) PLoS Pathog. 2016 Oct 19;12(10):e1005951. (PMID: 27760231) Mol Microbiol. 2006 Oct;62(1):187-200. (PMID: 16987177) |
| Grant Information: | R25 GM154345 United States GM NIGMS NIH HHS; R00-DE029228 United States NH NIH HHS; UL1 TR002369 United States TR NCATS NIH HHS; 001 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; R35-DE028252 United States NH NIH HHS; K99-DE029228 United States NH NIH HHS; R25-DE032536 United States NH NIH HHS; K99 DE029228 United States DE NIDCR NIH HHS; R25 DE032536 United States DE NIDCR NIH HHS; R35 DE028252 United States DE NIDCR NIH HHS; R25-GM154345 United States NH NIH HHS; R00 DE029228 United States DE NIDCR NIH HHS |
| Contributed Indexing: | Keywords: Streptococcus; fatty acid biosynthesis |
| Substance Nomenclature: | 0 (Fatty Acids, Monounsaturated) |
| Entry Date(s): | Date Created: 20260807 Date Completed: 20260917 Latest Revision: 20260919 |
| Update Code: | 20260919 |
| PubMed Central ID: | PMC13584702 |
| DOI: | 10.1128/jb.00026-26 |
| PMID: | 42565831 |
| Βάση Δεδομένων: | MEDLINE |
καταχωρήστε σχόλιο πρώτοι!